Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:21 PM
Ignite Modification Date:
2025-12-24 @ 10:21 PM
NCT ID:
NCT01111435
Eligibility Criteria:
Inclusion Criteria:
* Stopped interferon (beta-1a or beta-1b) within the past 30 days
* About to start or started glatiramer acetate (Copaxone®) within the past 21 days.
* At least 18 years of age
* Has spasticity at the beginning of the study
* Able to ambulate with unilateral support or without support
* Understands, speaks and reads English
Exclusion Criteria:
* Severe Gait Disability or Total Gait Disability
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01111435
Study Brief:
Protocol Section:
NCT01111435